Analysis Looks at SGLT2 Inhibitors Across Diabetes, Heart Failure, CKD
Sodium-glucose transporter 2 (SGLT2) inhibitors decrease the risk of acute kidney injury and severe hypoglycemia for those with diabetes, heart failure, and chronic kidney disease (CKD) but increase the risk of diabetic ketoacidosis.
What Are the Most Common Reasons for Hospital Admissions for Patients With Diabetes?
Soft tissue and bone infections, urinary tract infections, stroke, and electrolyte disorder top the reasons why patients with diabetes are admitted to the hospital at greater frequency and cost compared with patients without the disease, according to a new study.
Dropping Race From eGFR Doubles Estimated Prevalence of CKD in Black Populations
The study results were released as nephrologists and others are awaiting the findings of a joint task force of 2 national kidney organizations looking at alternative approaches to estimating glomerular filtration rate.